SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2016

Segment Information

Financial information for the company’s segments is as follows.

	Three months ended
	March 31,
(in millions)	2016		2015
Net sales
Renal		$      898		$      913
Hospital Products		1,477		1,490
Total net sales		$   2,375		$   2,403
EBITDA
Renal		$      122		$        85
Hospital Products		509		487
Total segment EBITDA		$      631		$      572
	March 31,		December 31,
(in millions)	2016		2015
Total assets
Renal		$    4,719		$    4,609
Hospital Products		6,787		6,632
Other		5,844		9,721
Total assets		$   17,350		$  20,962

EBITDA to Income from Continuing Operations Reconciliation

The following is a reconciliation of segment EBITDA to income from continuing operations before income taxes per the condensed consolidated statements of income.

	Three months ended
	March 31,
(in millions)	2016			2015
Total segment EBITDA	$	631		$	572
Reconciling items
Depreciation and amortization		(189	)		(187	)
Stock compensation		(23	)		(29	)
Net interest expense		(28	)		(30	)
Business optimization items		(5	)		—
Certain foreign currency fluctuations and hedging activities		22			108
Net realized gains on Retained Shares transactions		3,239			—
Net loss on debt extinguishment		(101	)		—
Other Corporate items		(217	)		(286	)
Income from continuing operations before income taxes	$	3,329		$	148